Determining the molecular flexibility of HIV-1 protease inhibitors.

被引:0
|
作者
Parish, C [1 ]
Sinclair, K [1 ]
机构
[1] Hobart & William Smith Coll, Dept Chem, Geneva, NY 14456 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
94-COMP
引用
收藏
页码:U602 / U602
页数:1
相关论文
共 50 条
  • [1] Molecular modeling of HIV-1 protease inhibitors.
    Castillo, H
    Parish, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U298 - U298
  • [2] Comparing the conformational flexibility of HIV-1 inhibitors.
    James, J
    Pratt, J
    Schram, K
    Parish, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U492 - U492
  • [3] QSAR studies of HIV-1 protease inhibitors.
    Garg, R
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U908 - U908
  • [4] CRYSTALLIZATION OF HIV-1 PROTEASE IN THE COMPLEX WITH PEPTIDOMIMETIC INHIBITORS.
    Jerabkova, H.
    Hasek, J.
    Brynda, J.
    Hradilek, M.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 317 - 317
  • [5] Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition
    Judd, DA
    Nettles, JH
    Nevins, N
    Snyder, JP
    Liotta, DC
    Tang, J
    Ermolieff, J
    Schinazi, RF
    Hill, CL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (05) : 886 - 897
  • [6] Molecular modeling of HIV protease inhibitors.
    Parish, C
    Schram, K
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U224 - U224
  • [7] Molecular modeling of HIV protease inhibitors.
    Lyons, T
    Parish, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U267 - U267
  • [8] Molecular modeling of HIV protease inhibitors.
    Parish, C
    Lyons, T
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U503 - U503
  • [9] Comparative molecular field analysis on cyclic urea compounds as HIV-1 protease inhibitors.
    Wang, X
    Welsh, WJ
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U501 - U502
  • [10] Updated clinical pharmacologic considerations for HIV-1 protease inhibitors.
    Anderson P.L.
    Fletcher C.V.
    [J]. Current HIV/AIDS Reports, 2004, 1 (1) : 33 - 39